← Back to Search

Behavioural Intervention

Smartphone-Based Smoking Cessation Interventions for Smoking Cessation (Smart-TR01 Trial)

Phase 2 & 3
Waitlist Available
Led By Michael S Businelle, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 27 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the Smart-T app, which helps low-income smokers quit by sending personalized messages when they are most likely to smoke. The app uses real-time data to support users in managing their cravings. The study aims to see if the Smart-T app is more effective than other smoking cessation apps.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~27 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 27 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Biochemically-Verified Smoking Cessation
Secondary study objectives
Change in cessation motivation
Change in cigarette availability
Change in smoking urge
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Smart-T + NRTExperimental Treatment1 Intervention
Smart-T provides content during the pre-quit and post-quit periods to prepare and support participants during their quit attempt. The Smart-T app contains multiple components including an EMA delivery and data transfer system, automated messages based upon EMA responses, and on-demand content. All participants will receive free nicotine replacement therapy (NRT).
Group II: NCI QuitGuide + NRTActive Control1 Intervention
The National Cancer Institute's QuitGuide app is a free smartphone app and is one of few apps that includes many of the recommendations detailed in the Clinical Practice Guideline. The QuitGuide app aims to help smokers understand their smoking patterns and develop the skills needed to quit smoking. QuitGuide provides content during the pre-quit and post-quit periods to prepare and support participants during their quit attempt. All participants will receive free nicotine replacement therapy (NRT).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smart-T + NRT
2019
Completed Phase 3
~460

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
472 Previous Clinical Trials
93,190 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,906 Previous Clinical Trials
41,011,575 Total Patients Enrolled
Michael S Businelle, PhDPrincipal InvestigatorUniversity of Oklahoma
1 Previous Clinical Trials
500 Total Patients Enrolled

Media Library

NCI QuitGuide (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03740490 — Phase 2 & 3
Smoking Cessation Research Study Groups: Smart-T + NRT, NCI QuitGuide + NRT
Smoking Cessation Clinical Trial 2023: NCI QuitGuide Highlights & Side Effects. Trial Name: NCT03740490 — Phase 2 & 3
NCI QuitGuide (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03740490 — Phase 2 & 3
~73 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top